Rainer Hamacher

4PUBLICATIONS
56CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jul 29, 2025
Phase II Trial of Ponatinib in Patients with Metastatic Gastrointestinal Stromal Tumor following Failure or Intolerance of Prior Therapy with Imatinib (POETIG Trial).

Johanna Falkenhorst, Philipp Ivanyi, Tom Schulz

|Aug 02, 2022
Comprehensive genomic and epigenomic analysis in cancer of unknown primary guides molecularly-informed therapies despite heterogeneity.

Lino Möhrmann, Maximilian Werner, Małgorzata Oleś

|Jul 14, 2022
Safety and Efficacy of 90Y-FAPI-46 Radioligand Therapy in Patients with Advanced Sarcoma and Other Cancer Entities.

Wolfgang P Fendler, Kim M Pabst, Lukas Kessler

|Sep 21, 2021
Localized Angiosarcoma, Not One Disease: A Retrospective Single-Center Study on Prognosis Depending on the Primary Site and Etiology.

Inna Schott, Sven-Thorsten Liffers, Farhad Farzaliyev

Pageof 1

Frequent Collaborators

3 joint publications

Sebastian Bauer

2 joint publications

Johanna Falkenhorst

2 joint publications

Marit Ahrens

2 joint publications

Jens T Siveke